Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the newly introduced Zepbound Self ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Telehealth firms Teladoc and LifeMD said on Thursday they had signed an agreement to offer Eli Lilly's weight-loss drug ...

For those looking for Zepbound (tirzepatide) online, our expert team has vetted the best places to buy this prescription-only weight loss drug. Plus, learn more about shortages, drug effectiveness ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

(Shelby Knowles/Bloomberg via / Getty Images ... 45% with its new products contributing more than $3.1 billion, driven mainly by strong demand for Mounjaro and Zepbound. The company also reported ...

Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...

The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.

Wegovy's maker, Novo Nordisk, is charging $499 per month for its direct-to-consumer product. Customers can't get their health insurance to pay for the either Eli Lilly's Zepbound vials or the ...